Regenerative Medicine Foundation
SUPPORTING REGENERATIVE MEDICINE
Our mission is to accelerate regenerative medicine to improve health and deliver cures
Regenerative Medicine
Committed to the ethical advancement of an innovative medicine powered by regenerative, restorative, and curative technologies.
The Regenerative Medicine Foundation only promotes safe medical treatments in service of health, life, and the alleviation of human suffering.
Latest News, Opinions and Video
Related to Regenerative Medicine and Stem Cell Research
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami
Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...
Stem cell therapy research could help patients with non-healing diabetic foot ulcers
Durham, NC – According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients...
Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19
Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...
Working with Policy Leaders in the United States
Making safe and effective treatments available for patients
Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics, ophthalmology, and other areas. Several well-designed clinical trials are being conducted under FDA investigational new drug (IND) protocols. At the same time, a handful of clinics have caused patient harm or made questionable claims, taking advantage of vulnerable patients and casting a negative light on this emerging science and industry.
Patient Advocacy
Ultimately, everything we do is in support of patients and families.
We inform, celebrate and mobilize the global advocacy movement consisting of patients, advocates and medical philanthropies, all supporting regenerative medicine, including stem cell research and cell therapies.
Endorsing Organizations
World Stem Cell Summit
We are a non-profit organization that produces the World Stem Cell Summit, Hosts Investor Meetings , Symposiums, and the Stem Cell Action Awards, and other events.
Our goals are to:
- Expand Knowledge
- Break Down Silos
- Encourage Collaboration
- Provide Networking Opportunities
RMF Leadership
accelerating regenerative medicine to improve health and deliver cures
Bernard Siegel is a public policy expert on stem cell research, regenerative medicine and cloning. He works to support the world’s leading stem cell researchers and advocates.
Bernard Siegel
Founder and Executive Director
Melissa King is a long time advocate for patients of chronic illness and disease, she is a non-profit and public affairs executive driving positive change for people, animals, and our planet!
Melissa King, JD
Policy
Since 2003 we have a track record fostering a supportive regulatory and societal framework for regenerative medicine.
Outreach
We educate the scientific community, public and media through our official, peer-reviewed, journal partner STEM CELLS Translational Medicine, the Regenerative Medicine Weekly Newsletter, social media channels, speaking engagements and media interviews.
Building a Trusted Network
Regenerative Medicine Foundation unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations.
Join Our Mailing List
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.